pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

Health policy experts debate Milton Friedman's role in U.S. health care challenges

Oct 16, 2026·read at STAT ↗Neutral

In a new STAT First Opinion series called Friendly Argument, two long‑time health policy scholars discuss the roots of America’s health‑care problems. The conversation features John E. McDonough, author of a recent book on the U.S. health‑care system, and Stuart Butler, a Brookings Institution scholar with a background at the Heritage Foundation.

McDonough argues that the country’s health‑care dysfunction can be traced to the neoliberal reforms inspired by economist Milton Friedman. He suggests that market‑oriented policies have eroded public investment and widened gaps in access and affordability.

Butler pushes back, saying the disagreement is more about how to implement reforms than about the underlying goals. He contends that the system’s failures stem from engineering and execution issues rather than from the basic principles of market‑based solutions.

The debate was conducted over Zoom and the transcript has been lightly edited for clarity. Both participants acknowledge their respect for each other’s perspectives while maintaining their differing views on the path forward.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: Is Milton Friedman to blame for America’s health care woes?”

read at STAT ↗
6,332 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
HERITAGE6MOUNTAINPATHRISINGUNIQUE
topics
Drug ShortageMicrobiomeRecallVaccine

related stories

  • Jun 1Opinion: The military’s medical corps has a serious recruitment problemSTAT
  • Aug 25How Trump’s cuts are reshaping America’s health systemSTAT
  • Jul 24Opinion: I may be one of the last middle-class medical students who could afford to become a doctorSTAT
  • 20h agoGSK laying off 1.2K+ in BelgiumBioSpace
  • Sep 145 drugmakers chasing Merck and Moderna in the cancer vaccine raceBioSpace